Investigating clinical associations between genomic alterations and prostate cancer lineage states using circulating tumor cell RNA sequencing.
Katharine E. Tippins(University of Wisconsin–Madison), David Kosoff(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin Carbone Cancer Center), Marina N. Sharifi(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Meghan Wells(Beth Israel Deaconess Medical Center), Amy K. Taylor(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), John M. Floberg(University of Wisconsin–Madison), Shannon R. Reese(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), V. Carreño(University of Wisconsin–Madison), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532